News - Merck & Co, Samsung Bioepis


Current filters:

Merck & CoSamsung Bioepis

Popular Filters

Merck & Co in biosimilars deal with Samsung Bioepis


US pharma giant Merck & Co (NYSE: MRK) has entered into an agreement with South Korea-based Samsung Bioepis…

Biogen IdecBiotechnologyMerck & CoPharmaceuticalProductionResearchSamsung Bioepis

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top